Guardant Health
GH
$30.06
Share price
8.83%
Change (1 day)
-42.28%
Change (1 year)
Categories
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.
Guardant Health (GH) - Total debt
Total debt on the balance sheet as of June 2023 : $1.33 B
According to Guardant Health 's latest financial reports the company's total debt is $1.33 B. A company’s total debt is the sum of all current and non-current debts.
Guardant Health - Total debt on balance sheet (from 2017 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $1.34 B | -0.99% |
| 2021-12-31 | $1.36 B | 60.51% |
| 2020-12-31 | $0.84 B | 2449.49% |
| 2019-12-31 | $33.25 M | 15296.3% |
| 2018-12-31 | $0.21 M | -67.22% |
| 2017-12-31 | $0.65 M | -96.13% |
| 2016-12-31 | $17.03 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Neogen NEOG | $0.88 B | -33.82% | 🇺🇸 USA |
 Natera NTRA | $0.43 B | -67.55% | 🇺🇸 USA |